Hondius Response Splinters as UK Adds Experimental Antiviral — May 20, 2026

MV Hondius hantavirus response is shifting from tracing to treatment stockpiles, with Britain receiving experimental favipiravir from Japan while countries apply different quarantine rules. Officials still frame wider public risk as low, but contact interviews may change restrictions. In this episode: Top stories: 1. Hantavirus: Britain secures experimental Japanese drug to strengthen response — The Economic Times https://economictimes.indiatimes.com/news/international/world-news/hantavirus-britain-secures-experimental-japanese-drug-to-strengthen-response/articleshow/131191634.cms 2. Step Back: If all these passengers and crew were tied to the same Hondius voyage, why are different countries using different rules — quarantine in some places, symptom monitoring in others — and what evidence would push health officials from one approach to the other? 3. Argentina Ushuaia Struggles with Hantavirus Threat as Tourism and Antarctic Cruises Face Rising Global Concerns — Travel And Tour World https://www.travelandtourworld.com/news/article/l56xzst4lyhi/ 4. Hantavirus: What you need to know - Virginia Department of Health — Virginia Department of Health https://www.vdh.virginia.gov/norfolk/2026/05/19/hantavirus-what-you-need-to-know/ Follow and rate Hantavirus Watch on Apple Podcasts or Spotify. Feedback? Email [email protected]